Floatz logo

10 assets in Therapy-Related Myeloid Neoplasm

Therapeutic assets addressing Therapy-Related Myeloid Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Fludarabine
Therapy-Related Myeloid Neoplasm
National Cancer Institute (NCI)P2B (62)
Busulfanum
Therapy-Related Myeloid Neoplasm
M.D. Anderson Cancer CenterP2B (57)
Clofarabine
Therapy-Related Myeloid Neoplasm
M.D. Anderson Cancer CenterP2B (57)
Cyclophosphamide
Therapy-Related Myeloid Neoplasm
M.D. Anderson Cancer CenterP2B (57)
Melphalan
Therapy-Related Myeloid Neoplasm
M.D. Anderson Cancer CenterP2B (57)
Rituximab
Therapy-Related Myeloid Neoplasm
M.D. Anderson Cancer CenterP2B (57)
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit
Therapy-Related Myeloid Neoplasm
M.D. Anderson Cancer CenterP2B (56)
NK-92
Therapy-Related Myeloid Neoplasm
M.D. Anderson Cancer CenterP2CCC (53)
Cytarabine
Therapy-Related Myeloid Neoplasm
National Cancer Institute (NCI)P1CC (43)
Uproleselan
Therapy-Related Myeloid Neoplasm
National Cancer Institute (NCI)P1CC (43)